CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 15,152 shares at $12.98 ($196,673)
- 4 Planned sale Director sold 2,860 shares at $13.95 ($39,897)
- 4 Grant or award President and CEO acquired 50,000 shares (grant or award)
- 4 Open-market buy 10% owner bought 520 shares at $10.60 ($5,512)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Grant or award Director acquired 207,100 shares (grant or award)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
- 4 Open-market buy 10% owner bought 207,100 shares at $11.11 ($2,300,881)
Page 2 of 18 · 354 filings